Evidence map›Paper›PMID 34512704›Full record

ArticleFrontiers in plant science2021

First Report of CRISPR/Cas9 Gene Editing in

Vera Pavese, Andrea Moglia, Elena Corredoira, Mª Teresa Martínez, Daniela Torello Marinoni, Roberto Botta

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Advances inFrontiers in plant science · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. First Report on Genome Editing via Ribonucleoprotein (RNP) inInternational journal of molecular sciences · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Vera PaveseDipartimento di Scienze Agrarie, Forestali e Alimentari (DISAFA), Università degli Studi di Torino, Grugliasco, Italy.
Andrea MogliaDipartimento di Scienze Agrarie, Forestali e Alimentari (DISAFA), Università degli Studi di Torino, Grugliasco, Italy.
Elena CorredoiraInstituto de Investigaciones Agrobiológicas de Galicia (IIAG)-Consejo Superior de Investigaciones Científicas, Santiago de Compostela, Spain.
Mª Teresa MartínezInstituto de Investigaciones Agrobiológicas de Galicia (IIAG)-Consejo Superior de Investigaciones Científicas, Santiago de Compostela, Spain.
Daniela Torello MarinoniDipartimento di Scienze Agrarie, Forestali e Alimentari (DISAFA), Università degli Studi di Torino, Grugliasco, Italy.
Roberto BottaDipartimento di Scienze Agrarie, Forestali e Alimentari (DISAFA), Università degli Studi di Torino, Grugliasco, Italy.
University of Turin · ITConsejo Superior de Investigaciones Científicas · ESInstituto de Investigaciones Agrobiológicas de Galicia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR/Cas9 has emerged as the most important tool for genome engineering due to its simplicity, design flexibility, and high efficiency. This technology makes it possible to induce point mutations in one or some target sequences simultaneously, as well as to introduce new genetic variants by homology-directed recombination. However, this approach remains largely unexplored in forest species. In this study, we reported the first example of CRISPR/Cas9-mediated gene editing in

Indexed as

Agrobacterium-mediated transformationEuropean chestnutgene knockoutphytoene desaturasesomatic embryostargeted mutagenesis

Identifiers

PMID34512704
PMCPMC8424114
OpenAlexW3194286226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.